Anti-inflammatory and related properties of 4-(p-biphenylyl)-3-hydroxybutyric acid.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000188:drug therapy*; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D004890:Erythema / Q000139:chemically induced / Q000188:drug therapy*; D003368:Gossypium; D006099:Granuloma / Q000139:chemically induced / Q000188:drug therapy*; D006168:Guinea Pigs; D006885:Hydroxybutyrates / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D010654:Phenylbutyrates / Q000627:therapeutic use; D051381:Rats; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D006885:Hydroxybutyrates; D010654:Phenylbutyrates; D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D007213:Indomethacin